(19)

(11)

EP 4 798 165 A1

(12)

(43) Date of publication: 02.09.2026 Bulletin 2026/36 (21) Application number: 24794820.1 (22) Date of filing: 25.10.2024

(51) International Patent Classification (IPC):  A61K 9/00(2006.01) A61K 9/107(2006.01) A61K 47/24(2006.01) A61K 8/55(2006.01) A61P 17/06(2006.01) A61P 17/18(2006.01) A61Q 19/00(2006.01) A61K 9/06(2006.01) A61K 47/14(2017.01) A61K 8/37(2006.01) A61K 31/20(2006.01) A61P 17/12(2006.01) A61Q 7/00(2006.01) (52) Cooperative Patent Classification (CPC): A61K 9/0014; A61K 47/14; A61K 47/24; A61K 8/37; A61K 8/553; A61Q 19/00; A61Q 7/00; A61K 9/06; A61K 9/107; A61P 17/06; A61P 17/12; A61P 17/18; A61K 31/593; A61K 31/573   C-Sets: A61K 31/593, A61K 2300/00; A61K 31/573, A61K 2300/00; (86) International application number: PCT/EP2024/080240 (87) International publication number: WO 2025/088126 (01.05.2025 Gazette 2025/18)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 27.10.2023 EP 23206293 (71) Applicant: Aurena Pharmaceuticals Holding AB 653 50 Karlstad (SE)	(72) Inventors: HOLMBÄCK, Jan 18594 Vaxholm (SE) RINWA, Vibhu 121 31 Enskededalen (SE) (74) Representative: AWA Sweden AB  Box 5117 200 71 Malmö 200 71 Malmö (SE)